...
首页> 外文期刊>Current urology reports. >Robotic and laparoscopic radical cystectomy in the management of bladder cancer.
【24h】

Robotic and laparoscopic radical cystectomy in the management of bladder cancer.

机译:机器人和腹腔镜根治性膀胱切除术治疗膀胱癌。

获取原文
获取原文并翻译 | 示例
           

摘要

To review the current status of robot-assisted and laparoscopic radical cystectomy (RARC and LRC) in the management of bladder cancer, published English literature was searched using the National Library of Medicine database. The experience with RARC is rapidly growing, and this minimally invasive option and has relatively better results than LRC. Both techniques allow an appropriate lymph node dissection in the hands of experienced and skilled surgeons at high-volume centers. The early and intermediate oncological outcomes of RARC and LRC compare favorably with open radical cystectomy (ORC). Extracorporeal urinary diversions are performed via a mini-incision in most cases and have better outcome than pure intracorporeal urinary diversions. RARC has taken over LRC at most of the centers where robot is available. The future of RARC with extracorporeal urinary diversion looks optimistic and has potential to supplant ORC, but with greater cost.
机译:为了回顾机器人辅助和腹腔镜根治性膀胱切除术(RARC和LRC)在治疗膀胱癌中的现状,使用国家医学图书馆数据库检索了已发表的英语文献。 RARC的经验正在迅速增长,这种微创的选择比LRC具有相对更好的效果。两种技术都可以在大容量中心的经验丰富且熟练的外科医生手中进行适当的淋巴结清扫术。 RARC和LRC的早期和中期肿瘤学结局优于开放性根治性膀胱切除术(ORC)。在大多数情况下,体外尿路改道是通过小切口进行的,其结果优于单纯的体内尿路改道。 RARC已在大多数有机器人的中心接管了LRC。具有体外尿液转移的RARC的未来看起来是乐观的,并且有潜力取代ORC,但成本更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号